Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2007 1
2008 4
2009 5
2010 8
2011 10
2012 12
2013 8
2014 7
2015 4
2016 9
2017 3
2018 9
2019 8
2020 9
2021 5
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

88 results
Results by year
Filters applied: . Clear all
Page 1
Ocrelizumab: a B-cell depleting therapy for multiple sclerosis.
Jakimovski D, Weinstock-Guttman B, Ramanathan M, Kolb C, Hojnacki D, Minagar A, Zivadinov R. Jakimovski D, et al. Among authors: hojnacki d. Expert Opin Biol Ther. 2017 Sep;17(9):1163-1172. doi: 10.1080/14712598.2017.1347632. Epub 2017 Jul 3. Expert Opin Biol Ther. 2017. PMID: 28658986 Review.
Recovery of cognitive function after relapse in multiple sclerosis.
Benedict RH, Pol J, Yasin F, Hojnacki D, Kolb C, Eckert S, Tacca B, Drake A, Wojcik C, Morrow SA, Jakimovski D, Fuchs TA, Dwyer MG, Zivadinov R, Weinstock-Guttman B. Benedict RH, et al. Among authors: hojnacki d. Mult Scler. 2021 Jan;27(1):71-78. doi: 10.1177/1352458519898108. Epub 2020 Jan 23. Mult Scler. 2021. PMID: 31971066
Use of natalizumab in multiple sclerosis: current perspectives.
Gandhi S, Jakimovski D, Ahmed R, Hojnacki D, Kolb C, Weinstock-Guttman B, Zivadinov R. Gandhi S, et al. Among authors: hojnacki d. Expert Opin Biol Ther. 2016 Sep;16(9):1151-62. doi: 10.1080/14712598.2016.1213810. Epub 2016 Jul 27. Expert Opin Biol Ther. 2016. PMID: 27413840 Review.
Aging and Brain Atrophy in Multiple Sclerosis.
Ghione E, Bergsland N, Dwyer MG, Hagemeier J, Jakimovski D, Paunkoski I, Ramasamy DP, Carl E, Hojnacki D, Kolb C, Weinstock-Guttman B, Zivadinov R. Ghione E, et al. Among authors: hojnacki d. J Neuroimaging. 2019 Jul;29(4):527-535. doi: 10.1111/jon.12625. Epub 2019 May 10. J Neuroimaging. 2019. PMID: 31074192
Dalfampridine benefits ambulation but not cognition in multiple sclerosis.
Satchidanand N, Drake A, Smerbeck A, Hojnacki D, Kolb C, Patrick K, Weinstock-Guttman B, Motl R, Benedict RH. Satchidanand N, et al. Among authors: hojnacki d. Mult Scler. 2020 Jan;26(1):91-98. doi: 10.1177/1352458518815795. Epub 2018 Dec 19. Mult Scler. 2020. PMID: 30566030 Clinical Trial.
Leptomeningeal, dura mater and meningeal vessel wall enhancements in multiple sclerosis.
Hildesheim FE, Ramasamy DP, Bergsland N, Jakimovski D, Dwyer MG, Hojnacki D, Lizarraga AA, Kolb C, Eckert S, Weinstock-Guttman B, Zivadinov R. Hildesheim FE, et al. Among authors: hojnacki d. Mult Scler Relat Disord. 2021 Jan;47:102653. doi: 10.1016/j.msard.2020.102653. Epub 2020 Dec 4. Mult Scler Relat Disord. 2021. PMID: 33333417
Sex-Specific Differences in Life Span Brain Volumes in Multiple Sclerosis.
Jakimovski D, Zivadinov R, Bergsland N, Ramasamy DP, Hagemeier J, Weinstock-Guttman B, Kolb C, Hojnacki D, Dwyer MG. Jakimovski D, et al. Among authors: hojnacki d. J Neuroimaging. 2020 May;30(3):342-350. doi: 10.1111/jon.12709. Epub 2020 May 11. J Neuroimaging. 2020. PMID: 32392376
High-mobility group box 1 in multiple sclerosis.
Sternberg Z, Sternberg D, Chichelli T, Drake A, Patel N, Kolb C, Chadha K, Yu J, Hojnacki D. Sternberg Z, et al. Among authors: hojnacki d. Immunol Res. 2016 Apr;64(2):385-91. doi: 10.1007/s12026-015-8673-x. Immunol Res. 2016. PMID: 26100980
88 results